Skip to content

Evidence Hub

Blog
Sep 1, 2023

What I saw at ICPE 2023

I just had the pleasure and privilege of attending the 39th International Conference on ...
Start Reading
Blog
Aug 29, 2023

Leveraging the SURF screening tool to understand how to identify whether RWE of effectiveness may be acceptable for regulatory decision-making for a clinical development program

Ulka Campbell, Ph.D., is Aetion’s Head of Scientific Strategy. In this role, she uses her ...
Start Reading
Publication
Aug 1, 2023

Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation.

The reporting of machine learning (ML) prognostic and diagnostic modeling studies is ...
Start Reading
Presentation
Aug 1, 2023

Demystifying HIPAA: Techniques for De-identifying Complex Multi-modal Data

Patricia Thaine, Co-Founder & CEO, Private AI
Start Reading
Publication
Jul 13, 2023

A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health

Our recent article in Scientific Reports entitled, A comparison of synthetic data ...
Start Reading
Presentation
Jun 14, 2023

Reuse health data safely via tech-enabled re-identification risk management

Braley Crandall, VP Operations, Replica Analytics
Start Reading
Blog
May 19, 2023

The Inflation Reduction Act Puts Real-World Evidence Front and Center

The drug price negotiation provisions of the Inflation Reduction Act (IRA) will ...
Start Reading
Blog
May 17, 2023

Implementation of synthetic data generation in the enterprise

By Khaled El Emam | Published: April, 2023 The following article was published by ...
Start Reading
Presentation
May 9, 2023

Privacy Protective Sharing of Health Datasets using De-identification and Synthetic Data Generation

Start Reading
Blog
May 5, 2023

Aetion submits comments to FDA on recent draft guidance on considerations for externally controlled trials

Earlier this week, Aetion submitted a letter to FDA commenting on the Agency’s recent ...
Start Reading
Blog
May 3, 2023

Setting Real-World Standards at ISPOR 2023

Aetion joins other industry experts at ISPOR 2023 to discuss standard-setting and ...
Start Reading
Publication
May 1, 2023

Practical Synthetic Data Generation

This book published by O'Reilly is an introduction to synthetic data generation ...
Start Reading
Publication
May 1, 2023

A method for generating synthetic longitudinal health data

Getting access to administrative health data for research is difficult and time-consuming ...
Start Reading
Blog
Apr 27, 2023

Scientist spotlight: A deeper dive on RCT-DUPLICATE

This week, the final results of the RCT-DUPLICATE (RCT-D) study were published in the ...
Start Reading
Article
Mar 1, 2023

Why is synthetic data used?

By Khaled El Emam | Published: March, 2023 The following article was published by ...
Start Reading
Article
Feb 22, 2023

Synthetic data puts privacy at the heart of AI projects

This article in the Globe and Mail article provides a summary of the transformative role ...
Start Reading
Blog
Feb 15, 2023

Privacy Assurance FAQ

What is Privacy Assurance? One of the benefits of synthetic data is that it has low ...
Start Reading
Blog
Feb 15, 2023

Synthetic Data Generation FAQ

What is synthetic data generation (SDG)? There are many ways to generate synthetic data. ...
Start Reading
Blog
Feb 15, 2023

Aetion® Generate FAQ

What is Generate? Aetion® Generate, formerly Replica Synthesis, is Aetion’s scalable ...
Start Reading
Publication
Feb 14, 2023

Prescription opioid fills following surgical abortion

Objective To characterize opioid fills after surgical abortion among US ...
Start Reading
Publication
Feb 14, 2023

Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity.

Importance Algorithms for classification of inpatient COVID-19 severity are necessary for ...
Start Reading
Publication
Feb 14, 2023

Selective serotonin reuptake inhibitor use and perioperative bleeding and mortality in patients undergoing coronary artery bypass grafting: a cohort study

Introduction Several small studies have reported inconsistent findings about the safety ...
Start Reading
Publication
Feb 14, 2023

Early real-world experience with emicizumab and concomitant factor VIII replacement products in adult male people with Hemophilia A without inhibitors

Aims To assess real-world use of emicizumab in adult people with hemophilia A (PwHA) ...
Start Reading
Publication
Feb 14, 2023

Categorization of COVID-19 severity to determine mortality risk

Purpose Algorithms for classification of inpatient COVID-19 severity are necessary for ...
Start Reading